A new generation needle- and adjuvant-free trivalent plague vaccine utilizing adenovirus-5 nanoparticle platform
Abstract A plague vaccine with a fusion cassette of YscF, F1, and LcrV encoding genes in an adenovirus-5 vector (rAd5-YFV) is evaluated for efficacy and immune responses in mice. Two doses of the vaccine provides 100% protection when administered intranasally against challenge with Yersinia pestis C...
Guardado en:
Autores principales: | Paul B. Kilgore, Jian Sha, Jourdan A. Andersson, Vladimir L. Motin, Ashok K. Chopra |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5455c5fff7c646eb8ffc606303806caf |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
New Insights into Autoinducer-2 Signaling as a Virulence Regulator in a Mouse Model of Pneumonic Plague
por: Eric C. Fitts, et al.
Publicado: (2016) -
Engineered trivalent immunogen adjuvanted with a STING agonist confers protection against Trypanosoma cruzi infection
por: Andrés Sanchez Alberti, et al.
Publicado: (2017) -
A Bacteriophage T4 Nanoparticle-Based Dual Vaccine against Anthrax and Plague
por: Pan Tao, et al.
Publicado: (2018) -
HLA GENE POLYMORPHISM IN PERSONS VACCINATED AGAINST PLAGUE
por: O. M. Kudryavtseva, et al.
Publicado: (2018) -
Efficiency of Human Plague Vaccination in Tuvinian Natural Plague Focus
por: K. M. Korytov, et al.
Publicado: (2019)